James J. Caruso - 23 Mar 2023 Form 4 Insider Report for Ra Medical Systems, Inc. (VTAK)

Role
Director
Signature
/s/ James Joseph Caruso
Issuer symbol
VTAK
Transactions as of
23 Mar 2023
Net transactions value
$0
Form type
4
Filing time
27 Mar 2023, 17:20:22 UTC
Previous filing
11 Jan 2023
Next filing
10 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMED Common Stock Conversion of derivative security $0 +1,779 $0.000000 1,779 23 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMED Series X Convertible Preferred Stock Conversion of derivative security $0 -2 -18% $0.000000 8 23 Mar 2023 Common Stock 7,932 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.
F2 Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.
F3 Series X Convertible Preferred Stock has no expiration date.